Atlas Trials

Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin

Clinical trial NCT02854748 · UNKNOWN

Trial details

NCT number
NCT02854748
Sponsor
Chong Kun Dang Pharmaceutical
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type II
Start date
2016-08-01
Primary completion
2016-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.